Infectious Diseases and Clinical Microbiology

Uzm. Dr. Melike Hamiyet Demirkaya

Doctor and researcher Ümraniye Eğitim ve Araştırma Hastanesi İstanbul
Klebsiella Infections

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Klebsiella Infections 2 publications
    Source: OpenAlex / PubMed MeSHView publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologysaglik.gov.trFrom source
  • Department name at the sourceEnfeksiyon Hastalıklarısaglik.gov.trFrom source
  • InstitutionÜmraniye Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workKlebsiella InfectionsExtracted from 2 publications · Model version —From source
  • Publications16 publicationsOpenAlex, Europe PMCFrom source
  • ORCID0000-0002-4767-1536ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://umraniyeah.saglik.gov.tr/TR-1514376/doktorlarimiz.html#melike-hamiyet-demirkayasaglik.gov.tr

Scientific work

Publications on Klebsiella Infections

16 publications
Publications by year Most: 4, in 2018
  1. 2005: 1 publication
  2. 2006: 0 publications
  3. 2007: 0 publications
  4. 2008: 0 publications
  5. 2009: 0 publications
  6. 2010: 0 publications
  7. 2011: 0 publications
  8. 2012: 0 publications
  9. 2013: 1 publication
  10. 2014: 0 publications
  11. 2015: 0 publications
  12. 2016: 0 publications
  13. 2017: 1 publication
  14. 2018: 4 publications
  15. 2019: 1 publication
  16. 2020: 1 publication
  17. 2021: 1 publication
  18. 2022: 4 publications
  19. 2023: 2 publications
  1. Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints

    Scandinavian Journal of Infectious Diseases, 2023

    DOI 10.1080/23744235.2023.2226709 PMID 37391868 11 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. Evaluation of Clinical Approach and Outcomes Staphylococcus aureus Bacteremia

    Infectious diseases & clinical microbiology, 2023

    DOI 10.36519/idcm.2023.191 PMID 38633900 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  3. Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting

    European Journal of Clinical Microbiology & Infectious Diseases, 2022

    DOI 10.1007/s10096-022-04425-4 PMID 35301623 42 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. High prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant Klebsiella pneumoniae bloodstream isolates

    Journal of Medical Microbiology, 2022

    DOI 10.1099/jmm.0.001629 PMID 36748503 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates

    Diagnostic Microbiology and Infectious Disease, 2022

    DOI 10.1016/j.diagmicrobio.2022.115745 PMID 35843111 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. Evaluation of the Epidemiology, Risk Factors, Predictors and Fatality Associated with Extremely Drug-Resistant Infections in Burn Patients

    Journal of Ankara University Faculty of Medicine, 2022

    DOI 10.4274/atfm.galenos.2022.97769 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  7. Changes in antimicrobial resistance and outcomes of health care–associated infections

    European Journal of Clinical Microbiology & Infectious Diseases, 2021

    DOI 10.1007/s10096-020-04140-y PMID 33586014 19 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. Efficacy of β‐lactam/β‐lactamase inhibitors to treat extended‐spectrum beta‐lactamase‐producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT‐SOT Project)

    Transplant Infectious Disease, 2020

    DOI 10.1111/tid.13520 PMID 33222379 26 citations (OpenAlex) Open-access full textSource: OpenAlex

  9. In vitro activity of ceftolozane–tazobactam and ceftazidime–avibactam against clinical isolates of meropenem-non-susceptible Pseudomonas aeruginosa: A two-centre study

    Journal of Global Antimicrobial Resistance, 2019

    DOI 10.1016/j.jgar.2019.09.016 PMID 31568882 34 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. Mucormycosis in Turkey

    Transplantation, 2018

    DOI 10.1097/01.tp.0000543601.70416.c0 Source: OpenAlex

View all 16 publications